Plague Clinical Presentation
- Author: Vinod K Dhawan, MD, FACP, FRCP(C), FIDSA; Chief Editor: Russell W Steele, MD more...
History
The incubation period of plague is 3-4 days (range, hours to 10 d). Sore throat may be the only complaint of patients with plague pharyngitis.
Bubonic plague
Patients complain of fever with abrupt onset and other constitutional symptoms. These symptoms usually manifest 3-6 days after contracting the organism but may appear in the first day or be delayed for longer than a week. Clinical manifestations of plague are the same for children and adults.
Fever with chills is virtually universal. Temperatures typically range from 38.5-40ºC.
Headache, malaise, and weakness are all very common.
An area of focal lymphadenopathy (bubo) develops (see the image below).
Inguinal bubo on upper thigh of a person with bubonic plague. Image courtesy of the Centers for Disease Control and Prevention (CDC). This bubo rapidly becomes very tender and can measure up to 10 cm. Over time, fluctuance develops, and the buboes often suppurate and drain. The most common site affected is the groin, followed by the axillary and cervical lymph nodes. Intra-abdominal buboes may present as an acute abdomen.
Nausea, vomiting, diarrhea, and abdominal pain are common. These, as well as the constitutional symptoms of headache and malaise, are thought to result from the gram-negative septicemia caused by Y pestis.
Patients with plague may complain of sleep disturbance, vertigo, and loss of memory. Weakness, delirium, stupor, ataxia, and speech disorders may also occur. These manifestations are due to the effects of endotoxin on the brain. Meningitis may develop. Children younger than 15 years appear to be more susceptible to meningitis.
Septicemic plague
Constitutional symptoms are similar to bubonic plague. Absence of palpable buboes differentiates the 2 forms.
Meningitis is 4 times more common in this form of the disease than with bubonic plaque. Additionally, pneumonic plaque occurs twice as often in septicemic plaque than in the bubonic form.
Patients with septicemia are often older than 60 years. They are usually less febrile, but mortality is higher.
Bacteremia may be so great that organisms can be visualized on peripheral smears.
Pneumonic plague
Patients primarily manifest fever and respiratory symptoms, including cough, hemoptysis, and chest pain. Tachypnea and dyspnea are also common.
Thin, watery, blood-tinged sputum becomes frankly bloody and mucopurulent as the disease rapidly progresses.
Plague bacillus can be cultured from sputum, and disease transmission is thought to occur up to 2 meters from a patient who may be coughing.
Physical
Generally, patients with any form of plague are toxic in appearance. Apprehension and tachycardia are also common.
All patients are febrile with chills.
A large bubo is palpable in the groin, axilla, or neck of patients with bubonic plague. The mass is fixed, edematous, exquisitely tender, and often surrounded by an area of erythema.
Intra-abdominal buboes may be accompanied by tenderness, guarding, and other peritoneal signs. Hepatomegaly can be present.
Septicemic patients present with tachycardia, tachypnea, and hypotension. Systolic blood pressures are usually less than 100 mm Hg. Differentiation of patients with septicemic plague from patients with other types of gram-negative sepsis is often difficult due to the similarity of signs and symptoms.
Patients with pneumonic plague manifest cough productive of bloody sputum, tachypnea, and dyspnea.
Fever and meningismus accompany plague meningitis.
Patients with plague pharyngitis resemble those with any other form of bacterial pharyngitis or tonsillitis. Large anterior cervical adenopathy may be appreciated.
Causes
Bacteriology
Y pestis is a nonmotile, pleomorphic, gram-negative coccobacillus that belongs to the family Enterobacteriaceae. Bipolar staining (giving the appearance of a closed safety pin) can be observed with Giemsa, Wayson, or Wright stains (see the images below).
Wright stain peripheral blood smear of patient with septicemic plague demonstrating bipolar, safety pin staining of Yersinia pestis. Although Wright stain often demonstrates this characteristic appearance, Giemsa and Wayson stains most consistently highlight this pattern. Courtesy of Jack Poland, PhD, Centers for Disease Control and Prevention (CDC), Fort Collins, CO. It grows at a wide range of temperatures (4-40ºC) but demonstrates optimal growth at room temperature.
Both an endotoxin and an exotoxin are produced, adding to the organism's pathogenicity.
Transmission
Human infection is usually acquired through the bites of infected rodent fleas. X cheopis, the Oriental rat flea, is the classic vector, but many other species of flea are also capable of transmitting plague. Typically, this form of transmission is common in crowded urban areas.
Plague can also be contracted from handling infected animals, especially rodents, lagomorphs (eg, rabbits or hares), and domestic cats, or through close contact with patients with pneumonic plague.
Person-to-person transmission is extremely rare; the last such transmission in the United States was reported in 1925. Person-to-person transmission occurs primarily through droplet exposure from a patient with the pneumonic form of the disease, although direct contact with body fluids can also be infectious.
Butler T. Plague into the 21st century. Clin Infect Dis. Sep 1 2009;49(5):736-42. [Medline].
Williamson ED. Plague. Vaccine. Nov 5 2009;27 Suppl 4:D56-60. [Medline].
Prentice MB, Rahalison L. Plague. Lancet. Apr 7 2007;369(9568):1196-207. [Medline].
Rocca P. The modern plague. Del Med J. May 2007;79(5):189-90. [Medline].
Ben Ari T, Gershunov A, Gage KL, et al. Human plague in the USA: the importance of regional and local climate. Biol Lett. Dec 23 2008;4(6):737-40. [Medline].
Thiagarajan B, Bai Y, Gage KL, Cully JF Jr. Prevalence of Yersinia pestis in rodents and fleas associated with black-tailed prairie dogs (Cynomys ludovicianus) at Thunder Basin National Grassland, Wyoming. J Wildl Dis. Jul 2008;44(3):731-6. [Medline].
Eisen RJ, Enscore RE, Biggerstaff BJ, et al. Human plague in the southwestern United States, 1957-2004: spatial models of elevated risk of human exposure to Yersinia pestis. J Med Entomol. May 2007;44(3):530-7. [Medline].
CDC. Human plague--four states, 2006. MMWR Morb Mortal Wkly Rep. Sep 1 2006;55(34):940-3. [Medline].
Ben Ari T, Gershunov A, Gage KL, et al. Human plague in the USA: the importance of regional and local climate. Biol Lett. Sep 2 2008;[Medline].
Cleri DJ, Vernaleo JR, Lombardi LJ, et al. Plague pneumonia disease caused by Yersinia pestis. Semin Respir Infect. Mar 1997;12(1):12-23. [Medline].
World Health Organization. Human plague in 2002 and 2003. Wkly Epidemiol Rec. Aug 13 2004;79(33):301-6. [Medline].
Gupta ML, Sharma A. Pneumonic plague, northern India, 2002. Emerg Infect Dis. Apr 2007;13(4):664-6. [Medline].
Josko D. Yersinia pestis: still a plague in the 21st century. Clin Lab Sci. Winter 2004;17(1):25-9. [Medline].
Neerinckx S, Bertherat E, Leirs H. Human plague occurrences in Africa: an overview from 1877 to 2008. Trans R Soc Trop Med Hyg. Feb 2010;104(2):97-103. [Medline].
Human plague: review of regional morbidity and mortality, 2004-2009. Wkly Epidemiol Rec. Feb 5 2009;85(6):40-5. [Medline].
Cornelius C, Quenee L, Anderson D, Schneewind O. Protective immunity against plague. Adv Exp Med Biol. 2007;603:415-24. [Medline].
Crook LD, Tempest B. Plague. A clinical review of 27 cases. Arch Intern Med. Jun 1992;152(6):1253-6. [Medline].
Dattwyler RJ. Community-acquired pneumonia in the age of bio-terrorism. Allergy Asthma Proc. May-Jun 2005;26(3):191-4. [Medline].
Dennis DT, Chow CC. Plague. Pediatr Infect Dis J. Jan 2004;23(1):69-71. [Medline].
Hoyle JD Jr, White LJ. Treatment of pediatric and adolescent mental health emergencies in the United States: current practices, models, barriers, and potential solutions. Prehosp Emerg Care. Jan-Mar 2003;7(1):66-73. [Medline].
Laudisoit A, Leirs H, Makundi RH, Van Dongen S, Davis S, Neerinckx S, et al. Plague and the human flea, Tanzania. Emerg Infect Dis. May 2007;13(5):687-93. [Medline].
Ligon BL. Plague: a review of its history and potential as a biological weapon. Semin Pediatr Infect Dis. Jul 2006;17(3):161-70. [Medline].
Mittal V, Bhattacharya D, Rana UV, Rai A, Pasha ST, Kumar A, et al. Prompt laboratory diagnosis in timely containment of a plague outbreak in India. J Commun Dis. Dec 2006;38(4):317-24. [Medline].
Russell P, Nelson M, Whittington D, et al. Laboratory diagnosis of plague. Br J Biomed Sci. Dec 1997;54(4):231-6. [Medline].
Smego RA, Frean J, Koornhof HJ. Yersiniosis I: microbiological and clinicoepidemiological aspects of plague and non-plague Yersinia infections. Eur J Clin Microbiol Infect Dis. Jan 1999;18(1):1-15. [Medline].
Solomon T. Hong Kong, 1894: the role of James A Lowson in the controversial discovery of the plague bacillus. Lancet. Jul 5 1997;350(9070):59-62. [Medline].
Tomaso H, Jacob D, Eickhoff M, et al. Preliminary validation of real-time PCR assays for the identification of Yersinia pestis. Clin Chem Lab Med. 2008;46(9):1239-44. [Medline].
Weir E. Plague: a continuing threat. CMAJ. Jun 7 2005;172(12):1555. [Medline].

